- Augments Senior Management Team with more than 30 Years Experience in
Biopharmaceutical Manufacturing, Engineering, Technical Services and
Validation -
PRINCETON, N.J., Feb. 14 /PRNewswire/ -- Laureate Pharma, Inc., a
full-service biopharmaceutical development and protein production company,
today announced the appointment of Gary Swan as Vice President of
Operations. In this newly created position, Mr. Swan will be responsible
for leading Laureate's manufacturing operations, which include upstream
processing, downstream processing, formulation and filling, facilities
maintenance, warehouse operations, and environmental, health and safety
regulations.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )
"We are delighted to welcome Gary to Laureate's senior leadership
team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With
his strong background and extensive experience of more than 30 years in
biopharmaceutical manufacturing operations, Gary will play a key leadership
role in driving and managing Laureate's tremendous growth."
Gary's experience includes biopharmaceutical manufacturing,
engineering, technical services, validation, and quality control. Most
recently, Gary held the position of Senior Director of Manufacturing at
Nastech Pharmaceuticals in Hauppauge, NY, a publicly traded
biopharmaceutical company developing innovative products based on
proprietary molecular biology-based drug delivery technologies. At Nastech,
Gary directed the operations at two manufacturing sites in New York and
Washington. In this capacity, he also led the planning and scheduling of
the production of R&D, clinical, and licensed products. Prior to Nastech,
Gary was the Vice President of Operations at VI Technologies in Melville,
NY, a publicly traded biopharmaceutical company with a focus on development
and manufacturing of virus-inactivated blood products and the purification
of proteins from blood components. At VI, Gary was responsible for
strategic planning and daily operation of a 100,000 SF sterile product
biopharmaceutical facility with a staff of 200. Gary has a BS in Biology
from Auburn University, Auburn, AL.
About Laureate Pharma, Inc.
Laureate Pharma is a full-service biopharmaceutical development and
protein production company located in Princeton, New Jersey. Laureate
Pharma offers superior bioprocessing services that accelerate new products
from development through production. Laureate provides a wide range of
specialized services from process design and development to full-scale cGMP
production, purification, aseptic filling, testing, validation, analytical
services, and regulatory support. Laureate is focused on two active
segments of the biopharmaceutical industry: monoclonal antibodies and
recombinant protein products. Laureate Pharma, Inc. is a partner company of
Safeguard Scientifics, Inc. (NYSE: SFE; http://www.safeguard.com), which provides
growth capital for entrepreneurial and innovative technology and life
sciences companies through expansion financings, corporate spin-outs,
management buyouts, recapitalizations, industry consolidations and
early-stage financings. For more information, contact Michael Cavanaugh,
Vice President Sales, Marketing, and Business Development at (609) 919-3400
or info@laureatepharma.com, or visit http://www.laureatepharma.com.
SOURCE Laureate Pharma, Inc.
 back to top
Related links:
http://www.laureatepharma.com
http://www.safeguard.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Michael Cavanaugh, Vice President Sales,
Marketing, and Business Development of Laureate Pharma, Inc.,
+1-609-919-3400, info@laureatepharma.com
|
